306 related articles for article (PubMed ID: 25245843)
1. Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis.
Qiu J; Cheng J; Wang Q; Hua J
Med Sci Monit; 2014 Sep; 20():1700-13. PubMed ID: 25245843
[TBL] [Abstract][Full Text] [Related]
2. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
3. Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Bofill Rodriguez M; Lethaby A; Jordan V
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD002126. PubMed ID: 32529637
[TBL] [Abstract][Full Text] [Related]
4. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
Gupta JK; Daniels JP; Middleton LJ; Pattison HM; Prileszky G; Roberts TE; Sanghera S; Barton P; Gray R; Kai J;
Health Technol Assess; 2015 Oct; 19(88):i-xxv, 1-118. PubMed ID: 26507206
[TBL] [Abstract][Full Text] [Related]
6. Combined hormonal contraceptives for heavy menstrual bleeding.
Lethaby A; Wise MR; Weterings MA; Bofill Rodriguez M; Brown J
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD000154. PubMed ID: 30742315
[TBL] [Abstract][Full Text] [Related]
7. Cyclical progestogens for heavy menstrual bleeding.
Bofill Rodriguez M; Lethaby A; Low C; Cameron IT
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD001016. PubMed ID: 31425626
[TBL] [Abstract][Full Text] [Related]
8. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Sangkomkamhang US; Lumbiganon P; Pattanittum P
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
[TBL] [Abstract][Full Text] [Related]
9. Surgery versus medical therapy for heavy menstrual bleeding.
Marjoribanks J; Lethaby A; Farquhar C
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD003855. PubMed ID: 26820670
[TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel intrauterine system versus medical therapy for menorrhagia.
Gupta J; Kai J; Middleton L; Pattison H; Gray R; Daniels J;
N Engl J Med; 2013 Jan; 368(2):128-37. PubMed ID: 23301731
[TBL] [Abstract][Full Text] [Related]
11. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Sayed GH; Zakherah MS; El-Nashar SA; Shaaban MM
Int J Gynaecol Obstet; 2011 Feb; 112(2):126-30. PubMed ID: 21092958
[TBL] [Abstract][Full Text] [Related]
13. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
Reid PC; Virtanen-Kari S
BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
[TBL] [Abstract][Full Text] [Related]
14. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
Campos RR; Baêta T; Silva-Filho A; Rezende SM; Rocha ALL
Contraception; 2020 Oct; 102(4):254-258. PubMed ID: 32470465
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(18):1-119. PubMed ID: 27990196
[TBL] [Abstract][Full Text] [Related]
16. Usual medical treatments or levonorgestrel-IUS for women with heavy menstrual bleeding: long-term randomised pragmatic trial in primary care.
Kai J; Middleton L; Daniels J; Pattison H; Tryposkiadis K; Gupta J;
Br J Gen Pract; 2016 Dec; 66(653):e861-e870. PubMed ID: 27884916
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Dominick S; Hickey M; Chin J; Su HI
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
[TBL] [Abstract][Full Text] [Related]
18. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
[TBL] [Abstract][Full Text] [Related]
19. The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.
Kaunitz AM; Inki P
Drugs; 2012 Jan; 72(2):193-215. PubMed ID: 22268392
[TBL] [Abstract][Full Text] [Related]
20. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
Endrikat J; Shapiro H; Lukkari-Lax E; Kunz M; Schmidt W; Fortier M
J Obstet Gynaecol Can; 2009 Apr; 31(4):340-347. PubMed ID: 19497153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]